Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The hypothalamic-pituitary-thyroid axis in major depression

P F Sullivan1, D A Wilson, R T Mulder

  • 1University Department of Psychological Medicine, Christchurch School of Medicine, New Zealand.

Acta Psychiatrica Scandinavica
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NDVI changes in the Arctic: Functional significance in the moist acidic tundra of Northern Alaska.

PloS one·2023
Same author

Dysregulation of Synaptic and Developmental Transcriptomic/Proteomic Profiles upon Depletion of MUNC18-1.

eNeuro·2022
Same author

Technological readiness and implementation of genomic-driven precision medicine for complex diseases.

Journal of internal medicine·2021
Same author

Stitching the synapse: Cross-linking mass spectrometry into resolving synaptic protein interactions.

Science advances·2020
Same author

Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease.

ACR open rheumatology·2019
Same author

Unraveling the genetic architecture of major depressive disorder: merits and pitfalls of the approaches used in genome-wide association studies.

Psychological medicine·2019
Same journal

AI-Associated Psychotic Phenomena: Collect Before You Classify.

Acta psychiatrica Scandinavica·2026
Same journal

Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

Acta psychiatrica Scandinavica·2026
Same journal

The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

Acta psychiatrica Scandinavica·2026
Same journal

Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

Acta psychiatrica Scandinavica·2026
Same journal

Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

Acta psychiatrica Scandinavica·2026
Same journal

Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

Acta psychiatrica Scandinavica·2026
See all related articles

Thyroid hormone levels, specifically the T4 difference, can differentiate between depressed individuals and controls. This T4 difference and maximal TSH response also predict antidepressant treatment outcomes, especially in males on desipramine.

Area of Science:

  • Neuroendocrinology
  • Psychiatry
  • Clinical Medicine

Background:

  • The thyroid axis plays a role in mood regulation.
  • Previous studies suggest thyroid function may be altered in depression.
  • Understanding these alterations can inform treatment strategies.

Purpose of the Study:

  • To assess if thyroid-axis measures differentiate depressed subjects from controls.
  • To determine if these measures predict antidepressant treatment response.
  • To explore relationships between thyroid variables and treatment outcomes in specific subgroups.

Main Methods:

  • Studied 105 subjects with major depressive episode and 41 controls.
  • Measured T4 difference (09:00-13:00), baseline TSH, and maximal TSH response to TRH (delta max TSH).

Related Experiment Videos

  • Utilized multivariate analyses to examine relationships with treatment outcome.

    • Main Results:

    • The T4 difference variable alone distinguished depressed from control subjects.
    • T4 difference and delta max TSH were independently related to antidepressant treatment outcome (14% variance).
    • These relationships were stronger in depressed males treated with desipramine (36% variance).

    Conclusions:

    • The T4 difference is a potential biomarker for distinguishing depression.
    • Thyroid-axis indices, particularly T4 difference and delta max TSH, are associated with antidepressant treatment response.
    • Findings support the utility of time-of-day thyroid hormone measurements in managing depression.